Issue link: https://www.e-digitaleditions.com/i/1087673
16 March 2019 Tablets & Capsules researcher to fix a formulation issue, they should have a breadth and depth of experience," Johanson said. "They should be able to ask the right questions. Does the for- mulation segregate? Is it friable? Is the material fine? Is it fluidizable? Does it have erratic flow? The answers to these questions should then guide their process design or product engineering." The future of contract analytical testing "The future of outsourcing contract development ser- vices in pharmaceuticals is bright," said Sidwell. "Contract development, testing, and manufacturing orga- nizations enable small companies to access expertise, capabilities, and capacity much faster and cheaper than they could by building those things for themselves." Johanson expects to see a higher demand for outsourc- ing of design of materials, where the contractor character- izes the material under process conditions, providing the necessary information to design a suitable product. "In sit- uations when a manufacturer has minimal amounts of starting materials and doesn't know a lot about those materials, a set of characterization tests using small amounts of material can allow them to move forward quickly and also help them design successful pilot studies." Sedlock believes this is also an opportunity for the industry to set guidelines and standardize requirements going forward. "If done right, there should be a set of standards for what type of studies should be performed during the development process," he says. "For exam- ple, product characterization during the R&D stage and a standard set of processes to follow will raise quality standards during the development process, which will hopefully cut down on headaches during manufacturing and scale-up." T&C References 1. https://www.grandviewresearch.com/press-release/ global-pharmaceutical-analytical-testing-outsourc ing-market 2. https://www.grandviewresearch.com/industry-analy sis/pharmaceutical-analytical-testing-outsourcing-market Material Flow Solutions, Gainesville, FL 352 379 8879 www.matflowsol.com Natoli Scientific, Telford, PA 636 926 8900 natoli.com Recro Gainesville, Gainesville, GA 770 534 8239 www.recrogainesville.com Common issues Although solid dosage pharmaceutical products come in many forms and target a variety of different health issues, there are common problems manufacturers encounter during development that require a level of expertise that companies don't always have in-house. "The most common problems our pharmaceutical clients bring to us are early phase chemistry, manufacturing, and controls (CMCs) for small molecule pharmaceutical development," Sidwell said. CMCs are necessary to sub- mit a new drug application (NDA), and the quickest way to get the information needed to speed a product to mar- ket is to outsource the testing. According to Sidwell, CMCs can include analytical method development for stability-indicating chromatographic methods, excipient compatibility studies, feasibility formulation development and stability testing, and clinical supply manufacture. Another prevalent pharmaceutical product issue is seg- regation, where a formulation's components do not remain uniformly distributed," Johanson said. "In addi- tion, our pharmaceutical clients are experiencing caking, hang-up, and flow problems. Sometimes the material must be engineered properly to optimize the manufactur- ing process, and sometimes the system needs to be rede- signed to meet the needs of the product. Often, problems don't appear until a manufacturer attempts to run the formulation at production scale. "Our clients regularly experience problems when they scale up a formulation," said Sedlock. "For example, a tablet for- mulation that ran well during R&D suddenly starts experi- encing capping, lamination, or sticking and picking on the high-speed tablet presses. All these problems can be traced back to the formulation." At that point in the man- ufacturing process, however, changing the formulation is not an option. Contractors can assist manufacturers by modifying the tooling, coatings, tablet design, or equip- ment setup so the formulation will run successfully. Qualities of a good contractor Once you've decided to outsource testing and analysis, be sure to pick the right contractor for your testing needs. "Make sure that you agree on the quality standard required for your project," said Sidwell. "Misalignments here can be trouble. The difference in time and effort between a good-enough experimental chromatography method and a validated method suitable for testing phar- maceutical registration stability is tremendous." According to Sedlock, whether it's a new or existing product, a company performing contract analytical test- ing should characterize all the raw materials used in the formulation, not just the API. "The company should also have the equipment to characterize a formulation's mechanical deformation properties. Understanding how a material deforms under compression can help you avoid scalability issues." To address problems with an existing formulation, the contractor must be able to identify what could poten- tially cause a process to fail. "If you're seeking a contract

